Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 618608, 11 pages
http://dx.doi.org/10.1155/2012/618608
Research Article

Polymerized-Type I Collagen Induces Upregulation of Foxp3-Expressing CD4 Regulatory T Cells and Downregulation of IL-17-Producing CD4 T Cells (Th17) Cells in Collagen-Induced Arthritis

1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Colonia Sección XVI, Tlalpan, 14000 Mexico City, DF, Mexico
2Department of Pathology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1, Colonia Sección XVI, Tlalpan, 14080 Mexico City, DF, Mexico
3Department of Experimental Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Colonia Sección XVI, Tlalpan, 14000 Mexico City, DF, Mexico

Received 13 June 2011; Revised 22 July 2011; Accepted 23 July 2011

Academic Editor: Zoltan Szekanecz

Copyright © 2012 Janette Furuzawa-Carballeda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. D. Brand, K. A. Latham, and E. Rosloniec, “Collagen-induced arthritis,” Nature Protocols, vol. 2, no. 5, pp. 1269–1275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. D. D. Brand, A. H. Kang, and E. F. Rosloniec, “Immunopathogenesis of collagen arthritis,” Springer Seminars in Immunopathology, vol. 25, no. 1, pp. 3–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. D. D. Brand, A. H. Kang, and E. F. Rosloniec, “The mouse model of collagen-induced arthritis,” Methods in molecular medicine, vol. 102, pp. 295–312, 2004. View at Google Scholar · View at Scopus
  4. C. Mauri, R. O. Williams, M. Walmsley, and M. Feldmann, “Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis,” European Journal of Immunology, vol. 26, no. 7, pp. 1511–1518, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Doncarli, L. M. Stasiuk, C. Fournier, and O. Abehsira-Amar, “Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis,” European Journal of Immunology, vol. 27, no. 6, pp. 1451–1460, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. C. T. Weaver, R. D. Hatton, P. R. Mangan, and L. E. Harrington, “IL-17 family cytokines and the expanding diversity of effector T cell lineages,” Annual Review of Immunology, vol. 25, pp. 821–852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. I. B. McInnes and G. Schett, “Cytokines in the pathogenesis of rheumatoid arthritis,” Nature Reviews Immunology, vol. 7, no. 6, pp. 429–442, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Furuzawa-Carballeda, M. I. Vargas-Rojas, and A. R. Cabral, “Autoimmune inflammation from the Th17 perspective,” Autoimmunity Reviews, vol. 6, no. 3, pp. 169–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Bettelli, M. Oukka, and V. K. Kuchroo, “TH-17 cells in the circle of immunity and autoimmunity,” Nature Immunology, vol. 8, no. 4, pp. 345–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Fujimoto, S. Serada, M. Mihara et al., “Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses,” Arthritis & Rheumatism, vol. 58, no. 12, pp. 3710–3719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Chimal-Monroy, T. Bravo-Ruiz, F. E. Krötzsch-Gómez, and L. Díaz de León, “Implantes de FibroquelMR aceleran la formación de hueso nuevo en defectos óseos inducidos experimentalmente en cráneos de rata: un estudio histológico,” Revista Biomédica, vol. 8, pp. 81–88, 1997. View at Google Scholar
  13. F. E. Krötzsch-Gómez, J. Furuzawa-Carballeda, R. Reyes-Márquez, E. Quiróz- Hernández, and L. Díaz de León, “Cytokine expression is downregulated by collagen-polyvinylpyrrolidone in hypertrophic scars,” Journal of Investigative Dermatology, vol. 111, no. 5, pp. 828–834, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Furuzawa-Carballeda, F. E. Krötzsch-Gómez, R. Espinosa-Morales, M. Alcalá, and L. Barile-Fabris, “Subcutaneous administration of collagen-polyvinylpyrrolidone down regulates IL-1β, TNF-α, TGF-β1, ELAM-1 and VCAM-1 expression in scleroderma skin lesions,” Clinical and Experimental Dermatology, vol. 30, no. 1, pp. 83–86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Furuzawa-Carballeda, J. Alcocer-Varela, and L. Díaz de León, “Collagen-PVP decreases collagen turnover in synovial tissue cultures from rheumatoid arthritis patients,” Annals of the New York Academy of Sciences, vol. 878, pp. 598–603, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Furuzawa-Carballeda, R. Rodríquez-Calderón, L. Díaz de León, and J. Alcocer-Varela, “Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen,” Clinical and Experimental Immunology, vol. 130, no. 1, pp. 140–149, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Furuzawa-Carballeda, A. R. Cabral, M. Zapata-Zuúñiga, and J. Alcocer-Varela, “Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial,” The Journal of Rheumatology, vol. 30, no. 2, pp. 256–259, 2003. View at Google Scholar · View at Scopus
  18. J. Furuzawa-Carballeda, R. Fenutria-Ausmequet, V. Gil-Espinosa et al., “Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial,” Clinical and Experimental Rheumatology, vol. 24, no. 5, pp. 521–528, 2006. View at Google Scholar · View at Scopus
  19. F. Lange, E. Bajtner, C. Rintisch, K. S. Nandakumar, U. Sack, and R. Holmdahl, “Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 4, pp. 599–605, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Zhou, W. Tang, Y.-X. Ren et al., “(5R)-5-Hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-γ production and its related signaling,” The Journal of Pharmacology and Experimental Therapeutics, vol. 8, no. 1, pp. 35–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Infante-Duarte, H. F. Horton, M. C. Byrne, and T. Kamradt, “Microbial lipopeptides induce the production of IL-17 in Th cells,” The Journal of Immunology, vol. 165, no. 11, pp. 6107–6115, 2000. View at Google Scholar · View at Scopus
  22. C.-Q. Chu, D. Swart, D. Alcorn, J. Tocker, and K. B. Elkon, “Interferon-γ regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17,” Arthritis & Rheumatism, vol. 56, no. 4, pp. 1145–1151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Manoury-Schwartz, G. Chiocchia, N. Bessis et al., “High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors,” The Journal of Immunology, vol. 158, no. 11, pp. 5504–5506, 1997. View at Google Scholar · View at Scopus
  24. K. Vermeire, H. Heremans, M. Vandeputte, S. Huang, A. Billiau, and P. Matthys, “Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice,” The Journal of Immunology, vol. 158, no. 11, pp. 5507–5513, 1997. View at Google Scholar · View at Scopus
  25. Y. Kageyama, Y. Koide, A. Yoshida et al., “Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-γ/receptor,” The Journal of Immunology, vol. 161, no. 3, pp. 1542–1548, 1998. View at Google Scholar · View at Scopus
  26. E. Bettelli, B. Sullivan, S. J. Szabo, R. A. Sobel, L. H. Glimcher, and V. K. Kuchroo, “Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis,” The Journal of Experimental Medicine, vol. 200, no. 1, pp. 79–87, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura, “Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice,” Journal of Immunology, vol. 171, no. 11, pp. 6173–6177, 2003. View at Google Scholar · View at Scopus
  28. E. Lubberts, M. I. Koenders, B. Oppers-Walgreen et al., “Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion,” Arthritis and Rheumatism, vol. 50, no. 2, pp. 650–659, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Sato, A. Suematsu, K. Okamoto et al., “Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction,” The Journal of Experimental Medicine, vol. 203, no. 12, pp. 2673–2682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Q. Yao, R. Li, and Z. G. Li, “A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis,” Annals of the Rheumatic Diseases, vol. 66, no. 3, pp. 423–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. L. K. Myers, Y. Sakurai, E. F. Rosloniec, J. M. Stuart, and A. H. Kang, “An analog peptide that suppresses collagen-induced arthritis,” American Journal of the Medical Sciences, vol. 327, no. 4, pp. 212–216, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Sakurai, D. D. Brand, B. Tang et al., “Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice,” Arthritis Research & Therapy, vol. 8, no. 5, article R150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Zhao, R. Li, J. He, J. Shi, L. Long, and L. Zhanguo, “Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells,” Rheumatology International, vol. 29, no. 1, pp. 9–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Segal, D. Caspi, M. Tishler, B. Fishel, and M. Yaron, “Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 9, pp. 1182–1185, 1988. View at Google Scholar · View at Scopus
  35. P. A. Hessian, J. Highton, A. Kean, Ch. K. Sun, and M. Chin, “Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma,” Arthritis & Rheumatism, vol. 48, no. 2, pp. 334–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Matsushita, M. Uzuki, H. Matsuno, E. Sugiyama, and T. Kimura, “Rheumatoid nodulosis during methotrexate therapy in a patient with rheumatoid arthritis,” Modern Rheumatology, vol. 16, no. 6, pp. 401–403, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Duarte, A. Agua-Doce, V. G. Oliveira, J. E. Fonseca, and L. Graca, “Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice,” PloS one, vol. 5, no. 5, p. e10558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Ghosh and M. S. Hayden, “New regulators of NF-κB in inflammation,” Nature Reviews Immunology, vol. 8, no. 11, pp. 837–848, 2008. View at Publisher · View at Google Scholar · View at Scopus